- Home
- AOD vs VIR Comparison
AOD vs VIR Comparison
Compare AOD & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOD
- VIR
- Stock Information
- Founded
- AOD 2006
- VIR 2016
- Country
- AOD United Kingdom
- VIR United States
- Employees
- AOD N/A
- VIR N/A
- Industry
- AOD Investment Managers
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- AOD Finance
- VIR Health Care
- Exchange
- AOD Nasdaq
- VIR Nasdaq
- Market Cap
- AOD 988.9M
- VIR 859.9M
- IPO Year
- AOD N/A
- VIR 2019
- Fundamental
- Price
- AOD $9.56
- VIR $5.80
- Analyst Decision
- AOD
- VIR Strong Buy
- Analyst Count
- AOD 0
- VIR 11
- Target Price
- AOD N/A
- VIR $25.73
- AVG Volume (30 Days)
- AOD 423.5K
- VIR 1.5M
- Earning Date
- AOD 01-01-0001
- VIR 11-05-2025
- Dividend Yield
- AOD 12.95%
- VIR N/A
- EPS Growth
- AOD 213.63
- VIR N/A
- EPS
- AOD 1.93
- VIR N/A
- Revenue
- AOD $72,962,082.00
- VIR $19,000,000.00
- Revenue This Year
- AOD N/A
- VIR N/A
- Revenue Next Year
- AOD N/A
- VIR $15.25
- P/E Ratio
- AOD $4.44
- VIR N/A
- Revenue Growth
- AOD N/A
- VIR N/A
- 52 Week Low
- AOD $6.99
- VIR $4.16
- 52 Week High
- AOD $9.14
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- AOD 51.64
- VIR 49.83
- Support Level
- AOD $9.50
- VIR $5.75
- Resistance Level
- AOD $9.71
- VIR $6.56
- Average True Range (ATR)
- AOD 0.10
- VIR 0.32
- MACD
- AOD -0.02
- VIR -0.04
- Stochastic Oscillator
- AOD 54.76
- VIR 10.76
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.